Cite
HARVARD Citation
Farhangnia, P. et al. (2022). Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives. Expert review of clinical immunology. pp. 1217-1237. [Online].